Cost-effectiveness of natalizumab in patients with Crohn's disease who have failed Anti-TNFα therapy

被引：0
|
作者：
Sands, Bruce
Wolf, Douglas
Panjabi, Sumeet
Niecko, Timothy
Hass, Steven
Lacey, Loretto
机构：
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, MGH Crohns & Colitis Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Atlanta Gastroenterol Associates, Atlanta, GA USA
[4] Elan Pharmaceut Inc, San Francisco, CA USA
[5] LLC, Niecko Hlth Econ, Escondido, CA USA
[6] Elan Pharmaceut Ltd, Pharmacoecon, Dublin, Ireland
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
10.14309/00000434-200809001-01025
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1025
引用
收藏
页码：S401 / S402
页数：2
相关论文
共 50 条
  • [31] Anti-TNF treatment of Crohn's disease
    Camoglio, L
    VanDeventer, SJH
    Tytgat, GNJ
    TRENDS IN INFLAMMATORY BOWEL DISEASE THERAPY 1996, 1997, : 111 - 117
  • [32] Anti-TNF agents in Crohn's disease
    Van Assche, G
    Rutgeerts, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) : 103 - 111
  • [33] Anti-TNF antibodies for Crohn's disease
    Camilleri, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16): : 1662 - 1662
  • [34] Corticosteroid avoidance in patients with crohn's disease who are newly initiated to therapy with an anti-TNF agent versus azathioprine
    Kane, Sunanda
    Hassig, Tanna
    Malpas, Phyllis
    Pennington, KellyAnne
    Smith, Teak
    Hicks, Rachel Velvet
    Dowdle, Merriman
    Jaganathan, Srihari
    Horst, Sara
    Schwartz, David A.
    PHARMACOTHERAPY, 2013, 33 (10): : E253 - E253
  • [35] Anti-TNF Alpha Therapy and Orofacial Crohn's Disease in Pediatrics
    Chapuy, Laurence
    Deslandres, Colette
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S71 - S71
  • [36] Anti-TNF induction and maintenance therapy for refractory Crohn's disease
    Hartnell, F. L.
    Radford-Smith, G.
    Jones, L.
    Sewell, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 62 - 62
  • [37] Impact analysis of expanding anti-TNF therapy for Crohn's disease
    Honeycutt, Amanda
    Breck, Andrew
    Bass, Sarah
    Esposito, Dominick
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 11 (02) : 79 - 88
  • [38] SEVERE CARDIOMYOPATHY SECONDARY TO ANTI-TNF THERAPY FOR CROHN'S DISEASE
    Rezik, Mohamed
    Mattina, Deirdre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1042 - 1042
  • [39] Natalizumab is Effective in the Treatment of Moderate to Severe Crohn's Disease Unresponsive to Anti-TNFα Agents
    Elvanides, Harry S.
    Burchett, Mary
    Ingram, Karen R.
    Annis, Kim
    Arsenescu, Razvan I.
    de Villiers, Willem J.
    GASTROENTEROLOGY, 2010, 138 (05) : S698 - S698
  • [40] Comparative Effectiveness of Vedolizumab Versus Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease
    Kappelman, Michael
    Lewis, James D.
    Zhang, Xian
    Lin, Feng-Chang
    Weisbein, Laura
    Chen, Wenli
    Burris, Jessica L.
    Dorand, Jennifer E.
    Parlett, Lauren E.
    Haynes, Kevin
    Nair, Vinit
    Kaul, Alan F.
    Dobes, Angela
    Long, Millie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S676 - S676
12345